baber/WOPTO huggingface dataset:
Patent DK-0553609-T3 (DK)
Inventor: KRAUSE REINHARD
IPC: B29C45/00
Filed: 1993-01-02
Granted: 1997-09-22
Abstract: In a method for the injection molding of objects of at least two independent parts, which are connected nondetachably but mutually rotatably, the subsequently produced part being injected at least partially into a mold recess of the previously produced part or injected at least partially about the previously produced part, an approximately hollow, cylindrical element (1) is molded to the part produced first in the region connecting this part to a rotatable part (18) that is to be produced subsequently, which hollow, cylindrical element (1) is thereupon surrounded by a mold (10) for the subsequent part (18) and, for the production of this part (18), either the outer space of the hollow, cylindrical element (1), which is closed off by a core, or the inner space (9) of this hollow, cylindrical element (1), which is not closed off, is injected for the production of this part (18), the part produced first being deformed in the region of the hollow cylinder (1) into an undercut with rotational symmetry by the pressure of the material injected.
Patent DK-0593368-T3 (DK)
Inventor: DUFLOT PIERRICK
IPC: C08B37/00
Filed: 1993-10-15
Granted: 1999-06-23
Abstract: Soluble glucose polymer consisting predominantly of 1-6 bonds, exhibiting a reducing sugars content lower than 0.5 %, and a content of products of molecular mass lower than or equal to 182 g which is lower than 1 %. The invention also relates to the process for preparing this glucose polymer, consisting in subjecting a glucose polymer to a hydrogenation stage and to a molecular sieving stage in order to remove the products of molecular mass lower than or equal to 182 g.
Patent DK-0658113-T3 (DK)
Inventor: LURQUIN CHRISTOPHE
IPC: A61K35/16
Filed: 1993-08-30
Granted: 2005-02-14
Abstract: The invention involves a nonapeptide derived from the tumor rejection antigen precursor encoded by gene MAGE-3. This nonapeptide is presented by HLA molecules HLA-A1. The resulting complexes are identified by cytolytic T cells. Such recognition may be used in diagnostics, or therapeutically.
Patent DK-0676160-T3 (DK)
Inventor: FISCHER KLAUS
IPC: A47G1/06
Filed: 1994-04-01
Granted: 1999-08-23
Abstract: The picture (1) is enclosed on its outside (24) by a profiled frame (3) which is closed on the side facing the viewer by a glass pane (10) and on the reverse side by a backing wall (12). The outside (23), facing the viewer, and the end side (33) of the glass pane (10) are held by the right-angled indentation (21) in the picture frame (2). The profiled frame is designed so that the picture lies in a plane behind the back (32) of the picture frame (2). The profiled frame has an outwardly directed continuous web (9) which adjoins the back of the picture frame and is detachably fixed to it. <IMAGE>
Patent DK-0678136-T3 (DK)
Inventor: JOHANNESSEN JOERGEN MOSBAEK
IPC: E03F5/12
Filed: 1994-01-10
Granted: 1997-08-04
Abstract: PCT No. PCT/DK94/00017 Sec. 371 Date Jun. 7, 1995 Sec. 102(e) Date Jun. 7, 1995 PCT Filed Jan. 10, 1994 PCT Pub. No. WO94/16159 PCT Pub. Date Jul. 21, 1994A hydraulic distribution and control unit has a chamber with an inlet (1a) and at least two subchambers. A partition wall (5) separates the subchambers one from another. One edge of the partition wall crosses the inlet to the main chamber, dividing the inlet into layers at different levels. The uppermost subchamber has an overfall edge (4a) and the lowermost subchamber includes an underflow (8).
Patent DK-0702841-T3 (DK)
Inventor: KIRCH JOHANNES
IPC: H01C7/12
Filed: 1994-05-26
Granted: 1997-10-13
Abstract: In an electric overvoltage diverter, especially for medium voltages, having a function block (1) and a housing (5) of insulating material surrounding it, the housing (5) is made of an elastically expandable material so that the function block (1) can be inserted into the housing (5) by elastically expanding the latter and easily removed therefrom. This simplifies the separation of the various materials of which the overvoltage diverter consists during the latter's disposal and makes them re-usable. The housing (5) of the overvoltage diverter is preferably made of silicone rubber.
Patent DK-0726942-T3 (DK)
Inventor: DE SMET WALTER
IPC: A61K38/00
Filed: 1994-10-26
Granted: 2002-04-15
Abstract: The present invention relates to human foam cells generated in vitro from monocyte/macrophage related cell lines which give rise to an average intracellular cholesterol amount of at least 139 + 36  mu g/mg cell protein as determined by HPLC, with said cholesterol being characterized by a degree of 46+6% of esterification as determined by HPLC. The invention also relates to monoclonal antibodies selected via said foam cells and which can be used for pharmaceutical and diagnostic purposes.
Patent DK-0684257-T3 (DK)
Inventor: BONNET JACQUELINE
IPC: A61P11/00
Filed: 1995-04-27
Granted: 2000-03-27
Abstract: Pseudopeptide derivs. and their enantiomers, diastereomers, epimers and addn. salts are new. R = naphthyl; 5,6,7,8-tetrahydronaphthyl or 1,2,3,4-tetrahydronaphthyl; and n = 1 - 8.
Patent DK-0741659-T3 (DK)
Inventor: SCHMIDT EDWARD HALE
IPC: B65D85/07
Filed: 1994-11-30
Granted: 1998-10-07
Abstract: An improved top opening, rectangular flexible bag for containing a stack of highly compressed flexible articles. The bag has front and back panels, two side panels and top and bottom panels, all of which are connected together to form an internal compartment for containing the stack under high compression. The stack is arranged within the bag in such a way that the side panels are under tension. The line of weakness defines the entire top portion of the bag which can be easily removed, thus exposing the entire contents of the bag for easy removal. The improvement to the bag is that the line of weakness is applied to the front and back panel of the bag simultaneously, thus providing perfect alignment of the lines of weakness where they intersect the side seals of the bag. The bag is further improved with a notch where the line of weakness intersects the side seal, thus significantly reducing the force to initiate the tear through the bead of plastic created by the side seal. A further improvement is that the line of weakness is applied in the machine direction as the bag is manufactured, thus requiring a simple, inexpensive, rotary cutting tool rather than an expensive, reciprocating die, and without negatively impacting line speeds.
Patent DK-0758397-T3 (DK)
Inventor: FALKNER FALKO-GUENTER
IPC: C12N15/863
Filed: 1995-04-28
Granted: 2005-10-10
Abstract: Defective poxviruses that lack a function imparted by an essential region of its parental poxvirus are provided for protein production and vaccination. A DNA polynucleotide encoding a protein is inserted into the defective poxvirus and placed under transcriptional control of a promoter. The defective poxvirus is viable when the lost function of the essential region is complemented by a host cell, transgenic animal or helper virus.
Patent DK-0794826-T3 (DK)
Inventor: HUMS ERICH
IPC: B01D53/86
Filed: 1995-11-28
Granted: 1999-05-03
Abstract: The selective catalytic reduction method has been adopted world-wide to decompose nitrogen oxides contained in flue gas. In this process, nitrogen oxides are contacted with a catalyst together with a reducing agent, mostly ammonia, and react into nitrogen and water. Because ammonia is difficult to handle, the storage, supply and dosage of ammonia are particularly complex. In order to achieve a high reaction rate, the invention provides for nitrogen oxides to be contacted with a catalyst at a temperature from 100 to 800  DEG C. The catalyst contains as catalytic components an aluminium silicate with a stratified structure, in particular mica. Transition metal ions, preferably lanthanum and/or cerium, are incorporated into the silicate grid. In this type of catalyst, nitrogen oxides decompose in the absence of a reducing agent. In addition, the nitrogen oxide decomposition rate is not adversely affected by the oxygen contained in the flue gas. In the temperature range from 200 to 600  DEG C, decomposition rates higher than 70 % were obtained with this catalyst. Catalysts according to the invention can replace state-of-the-art catalysts that work with a reducing agent to reduce the nitrogen oxide content of waste gas, for example for scrubbing flue gas or waste gas from power stations or internal combustion engines.
Patent DK-0726077-T3 (DK)
Inventor: FUJIBAYASHI YASUHISA
IPC: A61K51/04
Filed: 1996-01-08
Granted: 2002-03-04
Abstract: The present invention relates to a diagnostic agent for hypoxia or mitochondrial dysfunction comprising: (a) a radioactive copper complex of a dithiosemicarbazone derivative or a radioactive copper complex of a diamine diol schiff base derivative as defined in claim 1; and (b) a pharmaceutically acceptable diluent or carrier. The diagnostic agent according to the present invention has a good transferability to the target tissue, reduction reaction affinity at a hypoxic site, high stability in a non-target site and rapid disappearance ability therefrom.
Patent DK-0815041-T3 (DK)
Inventor: LAIDLER KEVIN OSWALD
IPC: B05B15/525
Filed: 1996-02-28
Granted: 2000-09-25
Abstract: A hollow body having a nozzle opening to discharge fluid as a jet or spray; the body comprising a first part having an inlet to admit fluid under pressure into the first part, and a second part movable relative to the first part and said first and second parts are relatively movable from an abutting position in which they define therebetween the nozzle opening and a fluid feed passage in the body and leading to the nozzle opening, and a cleaning position in which the fluid feed passage is split open longitudinally and the nozzle opening is split open to expose the nozzle and passage defining and abutting surfaces of said parts, for cleaning.
Patent DK-0773924-T3 (DK)
Inventor: MAURO MARINA
IPC: C07C229/62
Filed: 1996-05-17
Granted: 1999-09-20
Abstract: The present invention refers to a process for the preparation of 5-amino-2,4,6-triiodo-1,3-benzenedicarboxylic acid dichloride, comprising the reaction in heterogeneous phase between 5-amino-2,4,6-triiodo-1,3-benzenedicarboxylic acid and thionyl chloride, in a solvent selected from the group consisting of: (C7-C16) linear or branched hydrocarbons, (C7-C8) aromatic hydrocarbons, 1,1,1-trichloroethane, n-butylacetate, diglyme (diethylenglycoledimethylether), and in the presence of a catalytic amount of a tertiary amine.
Patent DK-0951774-T3 (DK)
Inventor: RITTER RUDOLF
IPC: G06Q30/00
Filed: 1996-12-23
Granted: 2001-02-05
Abstract: A process is disclosed for transmitting orders over a telecommunication network, in particular for transmitting orders for products, information requests or payment transactions, between a plurality of subscribers of the telecommunication network and at least one supplier. The following steps are carried out when transmitting an order: a connection (100) is established between a subscriber and an operation unit (4); a short message (3) input by the subscriber is transmitted over the telecommunication network. The short message contains at least information (34) on the product, information (32) on the supplier and a sum (36). The subscriber is automatically recognised (300) by the operation unit (4); the sum is checked; the subscriber address (47) is read (312) out of a data bank (46) in which the addresses of the subscribers of the telecommunication network are stored; the information contained in the short message (3) input by the subscriber is linked (314) to the subscriber address (47); the linked data (5) are transmitted (400, 402, 406) to the supplier; and when a product is ordered or payment made, the account of the subscriber at the network operator, in a bank or at a credit card institute is charged and the account of the supplier is credited.
Patent DK-0816344-T3 (DK)
Inventor: IMWINKELRIED RENE DR
IPC: C07D239/48
Filed: 1995-04-25
Granted: 2003-10-06
Abstract: Production of 2,5-diamino-4,6-dichloropyrimidine of formula (I) comprises: a) cyclising a dialkyl aminomalonate of formula R1OC(=O)CH(NH2)C(=O)OR1 (II) with guanidine; b) chlorinating the resulting 2,5-diamino-4,6-dihydroxypyrimidine or formula (III) in the presence of an amide of formula HC(=O)R2 (IV); and c) reacting the 2-amino-4,6-dichloro-5-(substituted methyleneamino)-pyrimidine of formula (V) obtained with a carboxylic acid of formula R6COOH (VI) in an aqueous alcohol. R1 = 1-6C alkyl; R2 = 5- or 6-membered N-heterocycloalkyl (optionally N-substituted) or NR3R4; R3, R4 = 1-6C alkyl or benzyl; R5 = NH2; R6 = 1-6C alkyl or 3-6C cycloalkyl.
Patent DK-0884959-T3 (DK)
Inventor: BRYANT JOHN W
IPC: A62B7/00
Filed: 1997-02-03
Granted: 2001-01-08
Abstract: A multi-part headband attachable to a face mask blank and a method of attaching the same. The multi-part headband has a unit length corresponding to the distance between the attachment locations as measured along a surface of the face mask blank or along an axis intersecting the attachment locations, to facilitate material handling and attachment using high speed manufacturing equipment. The headband material is positioned along the headband path and attached at the left and right headband attachment locations. At least one longitudinal score line is formed in the headband material extending generally along the headband path, whereby the at least one longitudinal score line defines a multi-part headband. The face mask blank may comprise a molded cup-shaped face mask, a flat folded face mask or a variety of other face mask constructions.
Patent DK-0889874-T3 (DK)
Inventor: FOX MARTIN EDWARD CHIROSCIENCE
IPC: C07C271/22
Filed: 1997-03-21
Granted: 2002-05-06
Abstract: PCT No. PCT/GB97/00811 Sec. 371 Date Sep. 25, 1998 Sec. 102(e) Date Sep. 25, 1998 PCT Filed Mar. 21, 1997 PCT Pub. No. WO97/35836 PCT Pub. Date Oct. 2, 1997The subject invention pertains to compounds of the formula Y1Y2N-(CH2)4-CH=C(Ph)-X wherein Y1 and Y2 are independently H or a removable blocking group, or Y1 and Y2 together are a removable divalent blocking group; and X is COOCH3 or a group convertible thereto. Such a compound may be cyclised, by Michael addition, to give methylphenidate, if necessary after removing blocking group(s) and converting X to COOCH3. The subject invention also pertains to methods for preparing compounds of the invention.
Patent DK-1028743-T3 (DK)
Inventor: ROBERTSON SARAH ANNE
IPC: A61K38/18
Filed: 1998-03-06
Granted: 2006-11-27
Abstract: A method of treating an infertility condition in humans or mammals, by exposure of a prospective mother to TGF² or derivative or analog of TGF². The exposure is advantageously in conjunction with one or more antigens of a prospective father so that a hyporesponsive immune reaction is mounted to the one or more antigens of the prospective father.
Patent DK-0941803-T3 (DK)
Inventor: LINDNER UWE
IPC: B24B7/17
Filed: 1999-03-04
Granted: 2004-08-16
Abstract: The double surface grinding machine (10) has at least two grinding wheels and at least one workpiece holder (3a-c) for the at least one workpiece (W1-3) The workpiece is moved by a conveyor (2) between the at least two grinding wheels (12,13). The workpiece holder is rotatably positioned in the conveyor. A drive mechanism (5) drives round the workpiece holders so that the workpieces engage with the grinding wheels.
Patent DK-1080211-T3 (DK)
Inventor: LEBENS MICHAEL R
IPC: A61K39/00
Filed: 1999-05-21
Granted: 2010-10-18
Abstract: A method of producing a thy A<SUP>-</SUP>strain of vibrio cholerae comprising the step of site-directed mutagenesis in the V. cholerae chromosome at the locus of the thy A gene SEQ ID NO: 1 of FIG. 1 , is described. Particularly, a Delta thy A strain of Vibrio cholerae lacking the functionality of the thy A is disclosed. This strain may comprise one or several episomal autonomously replicating DNA elements, such as plasmids, having an optionally foreign, e.g. E. coli, functional thy A gene that enables the strain to grow in the absence of thymine in the growth medium, and optionally having a structural gene encoding a homologous or heterologous protein. Further, proteins encoded by a structural thy A gene and the 5'-flanking region are described as SEQ ID NO: 4 of FIG. 4 and SEQ ID NO: 5 of FIG. 5 , respectively. Additionally, a vaccine comprising a Vibrio cholerae Delta thy A strain of the invention or a thy A<SUP>-</SUP>strain of Vibrio cholerae produced by the method of the invention is disclosed.
Patent DK-1103017-T3 (DK)
Inventor: SHIRLEY DIANNE BETH
IPC: G03C9/08
Filed: 1999-07-23
Granted: 2004-06-21
Abstract: A process is provided for producing a polymeric layer having a desired image thereon or a three dimensional article comprising a number of such layers in which a layer of a liquid photocurable composition which comprises photo colorable particles is cured by light and selected areas thereof are irradiated with light of a different dose, thereby forming the desired image which composition comprises particles dispersed in it which are micro-capsules containing a photosensitive color changing composition within a barrier layer which is substantially impermeable to the components of the color changing composition or are solid particles comprising an immobilized photosensitive color changing composition. The process permits the use of the same initiating mechanism to cure the resin and to change the color of the particles.
Patent DK-1124436-T3 (DK)
Inventor: VAARALA OUTI
IPC: A23L33/00
Filed: 1999-09-29
Granted: 2005-06-27
Abstract: The invention relates to a method of removing bovine insulin from a liquid fat-free proteinous material originating from cow's milk, wherein the liquid fat-free proteinous material originating from cow's milk, the material having a pH of 2 to 8, at a temperature below 65° C., is contacted with an adsorption resin, whereby the weight ratio of the proteinous material to be treated to the adsorption resin is at most 100:1, optionally combining with said resin treatment at least one ultra and dia-filtration treatment of the proteinous material, and, if necessary, the liquid material so obtained is concentrated into a protein concentrate and optionally dried to powder. The invention further relates to a substantially bovine insulin-free proteinous material so obtained, and to its use as the protein part or raw material in the preparation of substantially bovine insulin-free infant formulae or other special nutritive preparations or consumption milk, other milk drinks or other milk preparations, or as a raw material therein.
Patent ES-2255901-T3 (ES)
Inventor: ZEBERMANN CHRISTOPH
IPC: H05K7/14
Filed: 2000-01-07
Granted: 2006-07-16
Abstract: The bus conductor section includes at least one connection module fixed to a support rail and having connections (A1, A2, B1...) for external conductors and a row of disc-shaped base-terminal supports (2). The bus conductor sections (10) of the individual base terminal supports are structurally separate from each other and comprise a board with metal pins dimensioned so that their ends can be used directly to contact a socket strip.
Patent ES-2241515-T3 (ES)
Inventor: HOFSAESS MARCEL
IPC: H01H37/54
Filed: 2000-02-16
Granted: 2005-11-01
Abstract: A pouch holds a temperature-dependent switching device (15) to protect a load (11) from excess temperature or current. The p has a first counter contact (24) for the switching device connected electrically to the load. A second counter contact (26) conn to an external connector (27) to supply power to the load. The pouch holds a detached switching device to connect directly to bo counter contacts when below its operating temperature.
Patent ES-2369251-T3 (ES)
Inventor: ETZENBACH NORBERT
IPC: C09D7/61
Filed: 2000-11-21
Granted: 2011-11-28
Abstract: A red iron oxide pigment (I) has a color saturation value (C asterisk ) of greater than 39 Cielab units. An Independent claim is included for the preparation of the pigment (I) by producing a fine suspension of hematite by mixing dilute nitric acid with elemental iron at above 90 degrees C followed by reaction of the suspension with iron (II) salts and alkali hydroxide in the presence of an oxygen containing gas or reaction of iron, iron (II) salt and oxygen-containing gas to form a hematite pigment suspension with optional isolation of the resulting pigment.
Patent ES-2269063-T3 (ES)
Inventor: BARGES NATHALIE
IPC: A61K36/736
Filed: 2000-08-17
Granted: 2007-04-01
Abstract: A pharmaceutical formulation in the form of a dry powder which comprises amoxycillin and clavulanate in a weight ratio of from 2:1 to about 16:1 and a pharmaceutically acceptable carrier or excipient and and flavouring agents which provide a strawberry flavour, further modified by the addition of extra components to add a creamy flavour or an extra fruity flavour.
Patent ES-2254143-T3 (ES)
Title: Procedimiento de control de una rosca conica y dispositivos de control correspondientes.
Inventor: NOEL THIERRY
IPC: G01B5/24
Filed: 2000-02-17
Granted: 2006-06-16
Abstract: Procedimiento de control de una rosca cónica macho (3) dispuesta en la periferia exterior de un elemento macho (1) situado a su vez en el extremo de un tubo metálico (101) y que comprende por lo menos un medio de estanqueidad (5, 7) situado cerca de este extremo, en el cual se controla el diámetro primitivo (D1) de la rosca en un plano de medición (P1) dado situado a la distancia L1 del plano de referencia (P0) del dibujo por medio de un aparato de medición plana de diámetro (51) que comprende una superficie de apoyo (54, 54¿), por lo menos dos superficies de contacto (60, 61) transversalmente a distancia la una de la otra y a distancia axial regulable de la superficie de apoyo y un medio de medición (55) del diámetro de un círculo situado en un plano transversal de medición (P1) y tangente a las superficies de contacto, comprendiendo dicho procedimiento las etapas siguientes: a) ajuste en el aparato de medición plana de diámetro (51) de la distancia LA entre la superficie de apoyo (54, 54¿) y el plano de medición (P1) en función de la distancia L1 elegida, b) regulación de dicho medio de medición en un valor preestablecido de la distancia transversal entre las superficies de contacto por medio de un bloque patrón (70) cuya cota característica es definida con respecto al valor estimado (D1e) del diámetro primitivo en el plano de medición (P1), c) medición en el plano de medición (P1) del diámetro de la rosca entre cúspides de hilos (D1s), disponiéndose el aparato de medición (51) a tope por su superficie de apoyo (54, 54¿) contra el extremo libre del elemento macho, d) comparación del diámetro medido entre las cúspides de hilos (D1s) con respecto a los límites del intervalo admisible.
Patent ES-2209829-T3 (ES)
Inventor: STEINEMANN SAMUEL G
IPC: A61F2/28
Filed: 2000-01-27
Granted: 2004-07-01
Abstract: A chemical factor contributes above all to the integration in bone of a titanium prosthetic device. The prosthetic device has hydrophilic properties and it has a large effective surface area which is conditioned by a suitable electrolyte comprising mono- and two-valent metals.
Patent ES-2211528-T3 (ES)
Title: Procedimiento y dispositivo para la soldadura de dos piezas.
Inventor: ENGELHARD GERHARD
IPC: B23K20/12
Filed: 2000-03-13
Granted: 2004-07-16
Abstract: Procedimiento para la soldadura de dos piezas de trabajo (1, 3), que limitan una zona de unión (5) entre sí, a) habiéndose introducido en un punto de inicio (7) en la zona de unión (5) y en una zona opuesta de la pieza de trabajo (1, 3) a ambos lados de la zona de unión (5) un punzón de fricción (23), b) desplazándose el punzón de fricción (23) soldando las piezas (1, 3) en un dispositivo de soldadura (25) a lo largo de la zona de unión (5), c) sacándose el punzón de fricción (23) después de la soldadura de las piezas (1, 3) desde la zona de unión (5) y caracterizado porque d) de esta manera (o después de un movimiento relevante (55) en una de las piezas (1, 3)) se puede introducir levantando proyecto entre (43) en un elemento a sacrificar.